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We show that most isolates of influenza A induce filamentous changes in infected cells in contrast to A/WSN/33 and A/PR8/34 strains
which have undergone extensive laboratory passage and are mouse-adapted. Using reverse genetics, we created recombinant viruses in the
naturally filamentous genetic background of A/Victoria/3/75 and established that this property is regulated by the M1 protein sequence, but
that the phenotype is complex and several residues are involved. The filamentous phenotype was lost when the amino acid at position 41 was
switched from A to V, at the same time, this recombinant virus also became insensitive to the antibody 14C2. On the other hand, the
filamentous phenotype could be fully transferred to a virus containing RNA segment 7 of the A/WSN/33 virus by a combination of three
mutations in both the amino and carboxy regions of the M1 protein. This observation suggests that an interaction among these regions of M1
may occur during assembly.
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Influenza virus particles can display different morpholo-
gies. Some isolates form long filaments up to several
micrometers long as they emerge from the cell, but other
well-studied laboratory-adapted strains produce 100-nm
spherical particles (Cox et al., 1980; Roberts and Compans,
1998; Smirnov et al., 1991). This implies that viral and host
cell factors may influence virus morphology, and that some
of the mutations that adapt virus for growth in different
substrates may concomitantly result in morphological
changes.
Below the host-derived lipid bilayer that forms the
envelope of the influenza A virus particle lies a layer of
matrix protein, M1. This is the most abundant protein of
the virion, and it possesses both nucleic acid and mem-
brane binding activity (Bucher et al., 1980; Wakefield and
Brownlee, 1989). The M1 protein is encoded by RNA0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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protein, M2, by using an alternative splicing strategy
(Inglis and Brown, 1981; Lamb and Choppin, 1981).
Expression of M1 protein alone can drive budding of
vesicles from the plasma membrane (Gomez-Puertas et al.,
2000; Latham and Galarza, 2001) and this observation
implies that M1 exerts a driving force for virus assembly
and release.
Evidence that the gene products of RNA segment 7,
namely, M1 and M2 proteins, play a role in influenza A
virus assembly comes from studies with an M2 specific
monoclonal antibody, 14C2. This antibody binds an epitope
present in the ectodomain of many strains of influenza A
virus M2 but reduces infectivity of just a subset of them
(Zebedee and Lamb, 1988). Influenza strain A/Udorn/72,
which readily forms filamentous virions, was used to select
for mutant viruses that displayed resistance to growth
inhibition by 14C2. Some of these mutants showed genetic
changes in M2, either in the antibody epitope in the
ectodomain, or even in the cytoplasmic domain, while other
mutants had single amino acid changes such as V31I or
V41A in the M1 protein (Zebedee and Lamb, 1989).
Interestingly, later studies showed that the mutant viruses
altered in M2 retained their filamentous morphology but
Fig. 1. Induction of filamentous changes at the surface of MDCK cells
infected with influenza A viruses. Cells were infected with influenza Avirus
strains at an moi of 0.1 –1 and fixed 24 h after infection with
paraformaldehyde. Viral antigen was stained using an antibody to either
H3 (polyclonal) or H1 (monoclonal) HA protein. Imaging was carried out
on Leica confocal microscope and all images are maximum projections. (A)
A/WSN/33 (H1N1); (B) A/Udorn/72 (H3N2); (C) A/England/41/72
(H3N2); (D) A/PortChalmers/73 (H3N2); (E) A/Scotland/52/92 (H1N1);
(F) A/Johannesburg/95 (H3N2); (G) A/Victoria/3/75 (H3N2); (H) A/PR8/
34 (H1N1).
Fig. 2. Cell surface changes in MDCK cells infected with recombinant A/
Victoria/3/75 viruses with altered RNA segment 7. MDCK cells were
infected with recombinant influenza A viruses at an moi of 1. Twenty-four
hours later, they were analyzed by immunofluorescent staining and
confocal microscopy (A and B), or by scanning electron microscopy (a
and b) for cell surface changes induced by infection. (A and a)
Recombinant virus W/V. (B and b) Recombinant virus Ud/V.
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particles (Roberts et al., 1998). Thus, specific sequences in
the M1 gene appear to control virus shape.
More recently, a reverse genetics approach has been
applied to the analysis of the role of M1 gene in deter-
mining influenza morphology (Bourmakina and Garcia-Sastre, 2003). Chimeric and mutant viruses containing
Udorn segment 7 RNAs were analyzed for morphology
and the results implied a critical role for amino acids at
positions 95 and 204 in M1 in filamentous particle
formation. Because many traits of influenza viruses have
been previously been shown to be multigenic and may be
affected by the genetic background of the ‘parent virus’
used in a particular study, it is important to perform
genetic analyses in the context of different strains and
subtypes of influenza A virus. We have used a similar
approach to the above study but have generated mutant
viruses in a different genetic background and here we
describe results that subtly differ from those previously
reported. This implies that other RNA segments may have
a critical influence on morphology. Clearly, the assembly
of influenza virus is a complex process dependent on
several virus and host cell genes.Results
Filamentous morphology is independent of subtype and is
the common phenotype for human influenza viruses
We obtained a panel of human influenza A virus isolates
and analyzed whether they induced filamentous changes on
the surface of infected cells. Some of the panel members had
not been passaged in eggs, whereas others, such as the A/
PR8/34, A/WSN/33, A/Udorn/72, and A/Victoria/3/75
strains had an extensive egg passage history. The panel
contained strains of the H1N1 subtype as well as of H3N2.
Fig. 3. Filamentous changes are not seen in all infected cells. MDCK cells
were infected with recombinant virus UdM1. (A) Immunofluorescence of
cell surface viral antigens visualized by confocal microscopy 24 h after
infection at moi of 1. (B) Scanning electron microscopy of infected cell
monolayer 24 h after infection at moi of 1.
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the majority of strains formed filaments in a proportion of
the infected MDCK cells (Fig. 1, panels B, C, D, E, F, and
G). In contrast, cells infected with the A/WSN/33 or A/PR8/
34 strains rarely display this appearance (Fig. 1, panels A
and H). This implies that the idea that influenza viruses formFig. 4. Mutant segment 7 cDNA introduced into recombinant viruses in this study
on A/WSN/33 segment 7. Shaded areas indicate sequences derived from A/Udorn/7
long filaments on infected cells; – , virus does not induce filaments on infected
filaments on a few cells; nv, no virus rescued from this construct.exclusively 100-nm-diameter spherical particles has arisen
from the extensive experimental use of the A/WSN/33 and
A/PR8/34 strains.
RNA segment 7 confers filamentous morphology
We employed a reverse genetic approach to investigate
the genetic basis of viral filament formation. Previous data
had implied a role for the M1 gene in this phenotype. We
therefore analyzed the effect of manipulating the M1 gene
within a genetic background, which supported filament
formation, A/Victoria/3/75 (Fig. 1G). Two single-gene
reassortants were rescued entirely from plasmid cDNAs
and designated Ud/V and W/V. Ud/V contains the A/
Udorn/72 segment 7 in the A/Victoria/3/75 genetic back-
ground, while W/V contains the A/WSN/33 segment 7
also in the Victoria background. The surfaces of MDCK
cells infected with the two recombinant viruses were
analyzed by confocal microscopy (Figs. 2A and B). Cells
infected with the Ud/V recombinant produced many long
surface filaments while most of those infected with the. (A) Recombinants based on Udorn M1 sequence. (B) Recombinants based
2 segment 7, white areas have A/WSN/33 sequences. F, virus induces many
cells; s, virus induces short filaments on infected cells; few, virus induces
Fig. 5. Fluorescent and SEM micrographs of recombinant viruses to study
loss of filamentous phenotype. MDCK cells were infected with recombi-
nant viruses at moi = 1 and analyzed 24 h later by immunofluorescent
staining for viral antigen. (A and a) Recombinant virus UdM1. (B and b)
Recombinant virus UdM1-41V. (C and c) Recombinant virus UdM1-95K.
(D and d) Recombinant virus UdM1-218T.
Table 1
Amino acid differences between M1 proteins of spherical (A/PR8/34 and
A/WSN/33) and filamentous (A/Udorn/72) influenza A viruses
Virus amino acid position 41 95 167 204 205 218
A/WSN/33 V K T D I T
A/PR8/34 V K T E V T
A/Udorn/72 A R A E V A/V
A/Victoria/3/75 A R A E V A
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scanning electron microscopy (Figs. 2a and b), which also
allowed clear visualization of long filaments extruding
from cells infected with virus with Udorn segment 7
RNA. Interestingly, both confocal analysis and scanning
electron microscopy showed that although many of the
cells infected with viruses with Udorn RNA segment 7
did produce filaments, others, although infected, did not
(Figs. 3A and B). Plaque-purified virus preparations also
only induced filamentous changes in a proportion of the
cells they infected (data not shown), suggesting that this
observation is not due to heterogeneity in the virus
preparation.
The M1 gene determines viral morphology
To determine which of the gene products of RNA
segment 7 was important for determining virus morphology,
chimeric cDNAs were generated which contained mixtures
of M1 and M2 proteins from a filamentous and a spherical
strain. A recombinant virus was recovered containing a
chimeric segment 7 RNA in which the M2 gene of A/Udorn/72 was exchanged for that of A/WSN/33 (Fig. 4A).
This virus, designated UdM1, induced a highly filamentous
appearance in infected cells (Figs. 5A and a). A reciprocal
chimeric virus in which segment 7 contained the A/WSN/33
M1 gene and the A/Udorn/72 M2 gene, WM1, was not
rescued, although both M1 and M2 proteins were expressed
in the primary transfected cells (data not shown). This
suggests that this combination of matrix gene sequences is
incompatible.
Our next approach was to map individual residues in
the M1 gene which contribute to the filamentous pheno-
type. For this purpose, we took advantage of the two
‘parental’ viruses described above, W/V and UdM1,
which both encoded the WSN M2 protein and thus
differed only in M1 sequence. This allowed us to study
the role of M1 residues in an otherwise completely
isogenic background.
The amino acids at positions 41, 95, and 218 in M1 strongly
influence the filamentous phenotype
A comparison of the amino acid sequences of the M1
proteins of the filamentous A/Udorn/72 and A/Victoria/3/75
viruses with that of the spherical A/WSN/33 and A/PR8/34
viruses indicated six residues which differed among them
(Table 1). Two residues at positions 204 and 205 were
unique to WSN M1. Because PR8 virus did not induce
filaments (Fig. 1, panel H), we considered it unlikely that
these two residues were dominant determinants of the
filamentous phenotype. To confirm this, we cloned the
RNA segment 7 of A/PR8/34 virus and introduced it into
the A/Victoria/3/75 genetic background by the reverse
genetics technique. This virus therefore contains WSN-like
sequence in M1 except at residues 204 and 205 where it is
Udorn-like. It also did not induce filamentous changes in
infected cells (data not shown). Therefore, although a
mutation E204D abrogates the filamentous phenotype
(Bourmakina and Garcia-Sastre, 2003), the opposite change
D204E does not confer filament induction to a virus with
WSN-like M1. The M1 database sequences revealed that
another residue which differed between Udorn and WSN
M1, position 167, often varied among threonine, alanine, or
isoleucine, for example, in the strains shown in Fig. 1, all of
which induced filaments. On the other hand, M1 sequences
of WSN and PR8 viruses differed from those of all other
human strains at positions 41, 95, and 218. We attempted to
address whether any one of these three amino acid residues
Fig. 6. Fluorescent micrographs of recombinant viruses to show acquisition
of filamentous phenotype. MDCK cells were infected with recombinant
viruses at moi = 1 and analyzed 24 h later by immunofluorescent staining
for viral antigen. Recombinant viruses: (A) W-41A; (B) W-95R; (C) W-
218A; (D) UdM1; (E) W-41A-95R; (F) W-41A-218A; (G) W-95R-218A;
(H) W-41A-95R-218A.
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ing any one of these in the UdM1 background abrogated
filament formation (Figs. 4A and 5), and also whether
introducing any or all of these changes into the WSN
background could confer the filamentous phenotype (Figs.
4B and 6).
We first engineered the change A41V in the chimeric
segment 7 (UdM1-41V) and rescued recombinant virus with
this mutation. This virus no longer formed filaments
detected by confocal microscopy (Fig. 5B), although anal-
ysis of the surface of cells analyzed by SEM indicated very
short extrusions were present (Fig. 5b). In contrast, a change
of R to K at position 95 did not affect the ability of UdM1
virus to form filaments (UdM1-95K, Fig. 5, panels C and c).
Thirdly, we considered residue 218. Sequencing various
clones, we obtained following reverse transcription and
PCR of our laboratory stock of A/Udorn/72 indicated that
the amino acid at position 218 was either A, as reported in
the database, or V. The chimeric virus rescued as UdM1
contained V at this position and was clearly filamentous,
whereas the rescued virus Ud/V had A at this position and
also strongly induced filaments in infected cells. Thus,
either A or V at this position was associated with filamen-
tous viruses but T was found in both WSN and PR8
spherical strains. Therefore, the change, A to T, was
engineered into the UdM1 background (UdM1-218T). This
virus induced filaments to the same extent as UdM1 (Fig. 5,
panel D).
Next, we performed reciprocal changes mutating amino
acids within the WSN M1 gene to those found in the
Udorn sequence (Fig. 4B). A mutation was engineered in
the WSN segment 7 cDNA to produce the single amino
acid change at position 41, from V to A. The recovered
virus, designated W-41A (Fig. 6, panel A), did produce
some filaments on the infected cell surface when analyzed
at high magnification, although they were much shorter
than those observed for Ud/V and UdM1. When residue 95
was changed from K to R, the phenotype of virus W-95R
was indistinguishable from that of a virus with wild-type
WSN segment 7 (Fig. 6, panel B). Similarly, mutant W-
218A bearing the change threonine to alanine at residue
218 also did not acquire the filamentous phenotype (Fig. 6,
panel C).
Lastly, we assessed whether combinations of changes at
these three residues were able to confer the filamentous
phenotype to a virus with WSN-like segment 7. Each
change was engineered in pairs, to create viruses, W-
41A-95R, W-41A-218A, and W-95R-218A, and in addi-
tion a triple mutant, W-41A-95R-218A, was recovered
(Fig. 4B).
None of the double mutant viruses showed a completely
filamentous phenotype, although short extrusions were
evident on some cells infected with W-41A-95R and W-
41A-218A (Fig. 6, panels E and F), and a few cells infected
with W-95R-218A displayed filamentous changes (Fig. 6G).
However, the triple mutant induced extensive filamentformation and was indistinguishable in phenotype from a
virus with Udorn segment 7 (Fig. 6, compare panels D and
H). This suggests that changes in the amino half and
carboxy half of the M1 protein were able to act in concert
to affect the virus morphology.
Fig. 7. The effect of antibody 14C2 against M2 on plaque formation by recombinant viruses. Viruses were plaqued in the absence of or presence of 3 Ag/ml
14C2 monoclonal antibody and remaining MDCK monolayers were stained after 3 days with crystal violet stain.
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viruses which vary in morphology
The sensitivity of recombinant viruses to growth inhi-
bition by the M2 specific antibody 14C2 was determined
using a plaque inhibition assay (Fig. 7). The virus with
WSN segment 7, W/V, continued to form plaques in the
presence of antibody, albeit of a smaller size. However,
some derivatives of the W/V virus became sensitive to
14C2 inhibition. Thus, plaque formation by the W-41A
mutant was partially inhibited in the presence of 14C2,
whereas the triple mutant W-41A-95R-218A failed to
produce any plaques in the presence of 3 Ag/ml antibody.
Conversely, the ability of the UdM1 virus to form plaques
was inhibited by 14C2, whereas the UdM1-41V mutant,
which contains only one amino acid change from UdM1,
produced plaques in both the presence and absence of
antibody. We further tested the inhibition of virus produc-
tion by the 14C2 monoclonal antibody by titrating the
yield from infected cells using both infectivity and HA
assays (Table 2). Although all viruses were inhibited in
the presence of 5 Ag/ml antibody, the extent of inhibition
varied significantly and in a manner that correlated with
the ability to induce filamentous changes on infected
cells.Table 2
Effects of anti-M2 monoclonal antibody 14C2 in virus yields
Virus Titers released virus
in absence/presence
of antibody (pfu/ml)
Percentage
of yield in
absence of
antibody
HAU Fold
reduction
in HAU
W/V ND NA 32/16 2
W-41A ND NA 16/2 8
W-95R-218A ND NA 16/8 2
W-41A-95R-
T218A
ND NA 16/4 4
Ud/V 2.8  104/1.4  103 5% 2/<2 NA
UdM1 3.6  107/7.7  105 2.1% 16/2 8
UdM1-41V 2.9  104/3.7  103 12.7% <2/<2 NADiscussion
The strains of influenza A virus that are commonly
studied by most laboratories are the A/WSN/33 and A/
PR8/34 strains. Notably, these two strains were the only
ones in the present study that did not form filaments. Indeed,
our study of a selection of recent isolates showed that the
filamentous phenotype is predominant and independent of
egg or cell passage or subtype. Other examples of filament
formation by recent isolates can be found in the literature
(e.g. see Liu et al., 2002). The characteristics of filamentous
changes on the infected cell surface varied among strains
(compare the appearance of cells in Fig. 1 infected with A/
England/42/72, panel C, and A/Port Chalmers/73, panel D,
with those infected with A/Johanesburg/95, panel F). These
differences may indicate a contribution of other viral genes
or of other changes in the M1 gene to the filamentous
phenotype. The sequence of the M1 gene of all of the
viruses tested in Fig. 1 is not available, but for those which
are sequenced, there is some limited but significant variation
in M1. Overall, our findings suggest that filament induction
is influenced by a constellation of sequences both in M1 and
in other viral genes. Thus, our recombinant virus Ud-41V
forms only short extrusions on cells, whereas the recombi-
nant W-95R-218A which differs from Ud-41V only at
residues 167, 204, and 205 forms clear filaments at least
on some cells. We conclude that many different residues in
M1 can affect filament induction, and those analyzed here
serve to illustrate the ease with which the phenotype can be
gained or lost. Moreover, it is clear that other viral genes
also affect whether viruses display cell surface filaments or
not. Thus, in agreement with earlier work (Roberts et al.,
1998; Zebedee and Lamb, 1989), we show here that a single
amino acid change from A at residue 41 to V in A/Udorn/72
M1 resulted in a loss of filament production. In contrast, a
more recent study (Bourmakina and Garcia-Sastre, 2003)
found the A41V change did not abrogate filament formation
but the K95R change did. The latter observations were made
within the context of the H1N1 A/WSN/33 viral genome, in
contrast to our own work, which is based on a genetic
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influenza RNA segments 4 and 6 which encode HA and NA
have been previously shown to result in irregularly shaped
virions (Jin et al., 1997; Mitnaul et al., 1996).
In our study, three genetic changes in WSN M1, at amino
acids 41, 95, and 218, were required simultaneously to
confer fully filamentous phenotype, although changes at
residues 95 and 218 also resulted in obvious filament
formation. This implies a functional interaction between
the two halves of the M1 protein. Both residues 41 and 95
lie on the outer surface of the three-dimensional structure of
the amino terminus of M1 (Sha and Luo, 1997). The
position of residue 218 is at present unknown as no structure
for the C terminus of M1 is available. The M1 protein self-
assembles into ribbon-like structures (Harris et al., 2001)
and it is possible that the amino acid changes at positions
41, 95, and 218 affect this process. Alternatively, mutations
such as those described here might influence the interaction
of the hypothetical ‘late domain’ of M1 (Hui et al., 2003)
with a host cell protein which is required for, or which
stimulates efficient budding from the plasma membrane.
Indeed, the host cell undoubtedly influences the expression
of the filamentous phenotype. For example, only polarized
cells formed filaments and an intact actin cortex is necessary
for filament formation because no filaments were produced
in the presence of cytochalasin D (Roberts and Compans,
1998). In the presence of jasplaklinolide, an inhibitor of
actin treadmilling, filament formation was disrupted and the
plasma membrane distribution of hemagglutinin and other
raft-associated proteins profoundly altered (Simpson-Holley
et al., 2002). We noted that some cells are reciprocal to
filament formation and that this could not be due to genetic
heterogeneity in the virus preparation. One explanation for
our observations is that cells infected at different stages of
their cell cycle may vary in the integrity of their actin cortex
and thus their ability to support filaments.
We did not quantify the filamentous phenotype of dif-
ferent mutants in this study. We were not satisfied that
methods for quantification used in previous studies would
add to our ability to describe the phenotype of a recombi-
nant or isolate. For example, filament quantity and length
have been estimated by the deposition of filaments onto
TEM grids (Bourmakina and Garcia-Sastre, 2003; Roberts
and Compans, 1998). This approach can be problematic
because longer filaments either do not attach to the TEM
grid or are lost during preparation. Indeed, these authors
never showed a filament longer than 3 Am and these were
extremely rare. Presumably because of this problem, Bour-
makina and Garcia-Sastre (2003) defined a filament as any
particle longer 300 nm. However, this is an unrealistic
description of the filaments we observe in our studies. In
this study, we have been able to describe both long filaments
and shorter cell surface extrusions (Figs. 5 and 6) by
visualization of the cell surface following immunofluores-
cent staining. However, because of the variation in filament
frequency we observed, a recombinant virus was onlydesignated as filamentous if an equal proportion of infected
cells produced filaments clearly visible with the confocal
microscope as for the Ud/V-infected control.
Sensitivity of virus to 14C2 inhibition correlated more
closely with the filamentous phenotype than with the se-
quence of the M2 ectodomain which contains the antibody
epitope. Thus, the virus UdM1 is sensitive to inhibition by
14C2 antibody although it shares the M2 sequence of the
naturally resistant virus WSN. Furthermore, recombinant
virus UdM1-41V with an M1 sequence identical to the 1A
mutant of Udorn described by Zebedee and Lamb (1989)
does not induce filaments and also demonstrated resistance
to 14C2. Conversely, viruses with WSN M2 sequence
became sensitive to 14C2 if filamentous, even if they only
showed short extrusions, for example, W-41A. However, it
should be noted that some other previously described 14C2
resistant mutants with changes in M2 (such as the mutant
termed 10A (Zebedee and Lamb, 1989) were more filamen-
tous than the wild-type virus (Roberts and Compans, 1998).
We did not rescue a virus with an M1 derived from A/
WSN/33 and an M2 from A/Udorn/72, although we could
detect that both proteins were produced in transfected cells
from the recombinant plasmid. On the other hand, Bourma-
kina and Garcia-Sastre (2003) did rescue a virus containing
this combination of M1 and M2 genes although they used an
unnatural coding strategy in their studies by separating M1
and M2 onto different segments, and were also working
within the WSN genetic background. Yasuda et al. (1994)
were also unable to rescue viruses with particular combina-
tions of M1 and M2. They never obtained a virus with a
chimeric segment 7 containing the A/Aichi/68 M1 and A/
WSN/33 M2 although they recovered virus with the reverse
chimeric segment 7. These data might imply either that a
functional match is required between M1 and M2 proteins
or that certain RNA sequences are incompatible within
segment 7.
The fact that only the WSN and PR8 viruses lack the
filamentous phenotype suggests that there has been a
selective advantage for the spherical form during the exten-
sive passage history of these strains. The A41V mutation
present in both these strains was previously shown to be
associated with adaptation of influenza viruses for growth in
mice (Ward, 1995). In addition, the high yield cell culture
growth characteristics of influenza A virus have previously
been attributed to the M1 gene (Yasuda et al., 1993, 1994).
A suggestion has been made that the binding of M1 to the
RNP is stronger for viruses which grow more efficiently in
culture and that this might affect morphology (Liu et al.,
2002). Because filamentous viruses are associated with
clinical isolates, it is tempting to suggest that there is some
advantage in vivo for a virus which can form filaments that
is not reflected during mouse passage. Other viruses induce
filamentous structures in infected cells. Interestingly, two of
these are respiratory pathogens, parainfluenza and respira-
tory syncytial virus (Brown et al., 2002; Yao and Compans,
2000). In future studies, it will be important to analyze
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represent the situation in their natural habitat, the respiratory
tract.Materials and methods
Cell culture
MDCK cells were used for virus rescue, propagation, and
immunofluorescence studies. Cells were maintained in Dul-
becco’s minimal essential medium supplemented with
20000 U/l each of penicillin and streptomycin, 5 ml of 2
mM L-glutamine, 1 essential amino acids, and 10% heat-
inactivated fetal calf serum. Cells were passaged every 4–5
days in 75-ml flasks. For the transfection step of the virus
rescue, 293T cells were used. These were passaged as above
using the same media. The day before transfection, 293Ts
were seeded into 12-well plates so as to be about 80%
confluent the next day. MDCKs were set up so as to be
confluent on day 2 of the rescue. All tissue culture reagents
were obtained from Gibco BRL and all plastic ware from
Falcon Plastics.
Viruses
Stock viruses were passaged in 10-day-old embryonated
eggs. After 48 h incubation, the allantoic fluids were
harvested, clarified by centrifugation (4000  g for 20Table 3
Primer sequences used for cloning and mutagenesis
Oligonucleotide primers used for cloning and manipulation
Position 218 A to T (Udorn like) 5VGGTGC
5VCACTC
italics sho
T to A (WSN like) 5VGGTGC
5VCACTC
italics sho
Position 95 R to K (WSN like) 5VGGGAA
5VCTATAC
C removes
K to R (Udorn like) 5VGGGAA
5VCCTATA
C removes
Position 41 A to V (WSN like) 5VGCTGG
5VCTTTAG
A/T is the
V to A (Udorn like) 5VGCAGG
5VCTTTAG
C/G is the
Overlap primers for UdM1WSNM2 5VGCGAT
making chimeras 5VGACGA
bold indic
WSNM1UdornM2 5VCGGAT
5VAACAA
bold indic
Segment seven termini common for both 5VAGTCA
WSN and Udorn 5VAGTCA
italics shomin at 4 jC) and stored in aliquots at 80 jC. Clinical
isolates and all recombinant viruses were passaged in
MDCK cells in serum-free medium containing 1 Ag/ml
trypsin.
Antibodies and reagents
A rabbit polyclonal antibody to A/Sydney/5/97, an H3N2
virus, was kindly provided by Dr. Maria Zambon (HPA,
Colindale) and was used routinely to stain for H3 hemag-
glutinin. Goat anti-rabbit-FITC conjugate was obtained
from Harlan Seralab and used at 1/100 dilution.
Cloning
RNA was extracted from allantoic fluid from infected
eggs (Boom et al., 1990) and reverse transcribed using
MMLV RT (Promega) and the RT primer (see Table 3).
cDNA was amplified with Vent polymerase (NEB) using
primers specific for segment 7 containing Sap1 restriction
sites adjacent to the start of the noncoding regions, followed
by a single round extension with Taq polymerase. Resulting
fragments were TA cloned into a TOPO vector (Invitrogen
PCR2.1) and then inserted into plasmid pPolIRTSapI. This
vector was kindly provided by Dr. Thomas Zuercher
(Glaxo-Smith-Kline) and has been previously described
(Jackson et al., 2002). The Sap1 fragment was inserted such
that human RNA polymerase I transcription produces an
RNA subsequently cleaved by the ribozyme to preciselyAGGCGATGAGAGCCATTGGGACTCATCCTAGCTCGAGTG 3V
GAGCTAGGATGAGTCCCAATGGCTCTCATCGCCTGCACC 3V
ws XhoI site, G/C is the base pair change
AGGCAATGAGAACCATTGGGACTCATCCTAGCTCGAGTG 3V
GAGCTAGGATGAGTCCCAATGGCTTCTCATTGCCTGCACC 3V
ws XhoI site, A/T is the base pair change
TGGCGATCCAAATAACATGGACAAAGCAGTTAAACTGTATAG 3V
AGTTTAACTGCTTTGTCCATGTTATTTGGATCGCCATTCCC 3V
a BstY1 site: A/T is the base pair change
CGGCGATCCAAATAACATGGACAGAGCAGTTAAACTGTATAGG 3V
CAGTTTAACTGCTCTGTCCATGTTATTTGGATCGCCGTTCCC 3V
a BstY1 site: G/C is the base pair change
AAAGAACACAGATCTTGAGGTTCTCATGGAATGGCTAAAG 3V
CCATTCCATGAGAACCTCAAGATCTGTGTTCTTTCCAGC 3V
base pair change
GAAGAACACCGATCTTGAGGCTCTCATGGAATGGCTAAAG 3V
CCATTCCATGAGAGCCTCAAGATCGGTGTTCTTCCCTGC 3V
base pair change
TCAAGTGATCCTCTCGTC 3V
GAGGATCACTTGAATCG 3V
ates WSN M2 sequence
TCAGGTGACCCTCTTGTT 3V
GAGGGTCACTTGAATCG 3V
ates Udorn M2 sequence
TGCTCTTCGGCCAGCAAAAGCAGGTAGATATTG 3V RT primer
TGCTCTTCTATTAGTAGAAACAAGGTAG 3V
ws the Sap1 site used for cloning into the pPol1RT vector
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containing segment 7 sequences from A/Udorn/72 and A/
WSN/33 were made by overlapping PCR. Two chimeras
were produced. The first contained the Udorn M1 and the
WSN M2 gene and the second contained WSN M1 and
Udorn M2. These cDNAs were inserted into the pPol1RT
vector for use in virus rescue. Mutations in the segment 7
cDNAs to alter the amino acid codons at residues 41, 95,
and 218 were made using a Stratagene ‘quick change’
mutagenesis kit and appropriate primers (Table 3).
Virus rescue
Virus rescue was carried out using plasmids kindly
provided by Dr. Thomas Zuercher (Glaxo-Smith-Kline).
The set consisted of 12 plasmids: four expression plasmids
with a CMV promoter, which direct expression of the
proteins of the viral polymerase complex PB1, PB2, PA,
and NP from strains A/Victoria/3/75. The remaining eight
plasmids contain cDNA copies of viral RNAs derived from
A/Victoria/3/75 inserted into the pPol1RT vector. The
rescue method used was adapted from Neumann et al.
(1999). Briefly, all 12 plasmids were transfected into 293T
cells in 12-well plates using Fugene 6. Each time the rescue
was carried out, a control of all 12 A/Victoria/3/75 plasmids
was included and wild-type virus was always rescued from
this experiment. To generate recombinant viruses, different
cDNAs representing mutated segment 7 RNAs were substi-
tuted in place of the equivalent A/Victoria/3/75 segment 7
plasmid. After 24 h, the transfected cells were removed from
the wells and mixed with MDCKs and co-cultured in 25-ml
flasks. The first 6–8 h of the co-culture was carried out in
10% serum after which the cells (now firmly attached to the
plastic) were washed briefly in serum-free media and the
media replaced with serum-free media containing 2.5 Ag
trypsin/ml (Worthington). The flasks were examined on day
4 of the rescue (at which time cytopathic effect could be
seen in the positive control flasks) and monitored daily
thereafter. Supernatants containing recombinant viruses
were harvested once the cell layers were completely
destroyed by the virus. The harvested supernatants were
spun at 4000  g at 4 jC for 20 min to remove the cell
debris and stored in aliquots at 80 jC. RT PCR was
carried out on the supernatants of the recovered viruses and
the amplified segment 7 cDNAs sequenced to confirm their
genotype.
Plaque assays
Plaque assays were carried out in confluent monolayers
of MDCK cells in 12-well plates. One hundred microliters
of each of the dilutions of the virus to be assayed was
applied to each well and incubated for 1 h. Cell layers were
then washed in PBS before being overlaid with 0.6%
agarose (Oxoid) in DMEM including 2 Ag/ml trypsin
(Worthington) and incubated at 34 jC. After 3 days, the
agarose was removed and the cells stained with crystalviolet dissolved in methanol and water. The anti-M2 anti-
body 14C2, used in the plaque reduction assay, was
obtained from Professor R.A. Lamb and included in the
overlay at a concentration of 3 Ag/ml.
Microscopy
MDCK cells were grown on glass coverslips until
completely confluent, infected at an MOI of approximately
0.1, and fixed 24 h after infection in 4% depolymerized
paraformaldehyde in PBS (pH 7.0). Fixation was carried out
on ice and the coverslips were then blocked in 5% BSA in
PBS before being treated with the primary antibody. The
stained coverslips were mounted in Vectorshield on glass
slides, sealed with nail varnish, and imaging carried out on a
Leica confocal microscope.
Cells were prepared for scanning electron microscopy
(SEM) by growth on Melinex plastic coverslips obtained
from Agar Scientific Ltd., cut into appropriate sized squares.
Eighteen hours after infection, the coverslips were fixed in
4% depolymerized paraformaldehyde containing 1.5% glu-
taraldehyde, dehydrated through an acetone series, and
critical point dried. Samples were sputtered with gold and
examined on a LEO FEG scanning microscope.Acknowledgments
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